Fractyl Health develops and sells medical devices, including its Revita device, from Burlington, Massachusetts. GUTS reports earnings on Wed, Nov 11, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 20 | Canaccord Genuity | Maintained | Buy | |
| Oct 19 | Morgan Stanley | Maintained | Hold | |
| Jul 1 | Craig-Hallum | Initiated | Buy | |
| Jun 4 | HC Wainwright & Co. | Reiterated | Buy |
Whale Options Flow
90DNo whale options trades in GUTS in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GUTS is in one of them and how their past GUTS trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered GUTS in an article yet. Here's the latest on the wider market.
About Fractyl Health
Fractyl Health is a medical device company based in Burlington, Massachusetts. It develops medical devices, including its Revita device, which carries a CE mark and is sold in the European Union and the European Economic Area. The company is also developing product candidates that must receive approval or certification from regulators such as the FDA and European notified bodies before they can be sold. Its products are subject to medical device rules in the EU and the United Kingdom.
- Headquarters
- Burlington, MA
- Founded
- 2010
- Website
- fractyl.com ↗